bms 180448 has been researched along with glyburide in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atwal, KS; Ferrara, FN; Green, DW; Grover, GJ; Monshizadegan, H; Rogers, WL; Sleph, P; Traeger, S; Wang, P | 1 |
| Atwal, KS; D'Alonzo, AJ; Grover, GJ; McCullough, JR; Sargent, CA | 1 |
| D'Alonzo, AJ; Darbenzio, RB; Grover, GJ; Hess, T; Sleph, PG | 1 |
| Grover, GJ; Mitroka, JG; Parham, CS; Whigan, DB | 1 |
| Lodge, NJ; Smith, MA | 1 |
| Behling, RW; Dzwonczyk, S; Grover, GJ; Malone, HJ; Sleph, PG | 1 |
| Baird, AJ; Behling, RW; Gomoll, AW; Grover, GJ; Malone, HJ; Roth, RA; Sargent, CS; Swillo, RE | 1 |
| Carr, CS; Grover, GJ; Pugsley, WB; Yellon, DM | 1 |
| Ahmed, SZ; Atwal, KS; Ding, CZ; Grover, GJ; Kelly, Y; Miller, AV; Misra, RN; Normandin, DE; Rovnyak, GC; Sleph, PG | 1 |
| Atwal, KS; Bajgar, R; D'Alonzo, AJ; Darbenzio, RB; Garlid, KD; Grover, GJ; Hess, TA; Lodge, NJ; Paucek, P; Sleph, PG; Smith, MA | 1 |
| Lee, BH; Seo, HW; Yoo, SE | 1 |
| Choi, WS; Lee, BH; Lee, CS; Lee, SH; Lim, JH; Seo, HW; Shin, HS; Won, HS; Yang, MK; Yi, KY; Yoo, SE | 1 |
| Carroll, WA; Coghlan, MJ; Gopalakrishnan, M | 1 |
1 review(s) available for bms 180448 and glyburide
| Article | Year |
|---|---|
Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.
Topics: Adenosine Triphosphate; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Calcium; Ion Channel Gating; Myocardial Ischemia; Potassium Channel Blockers; Potassium Channels; Urinary Incontinence | 2001 |
12 other study(ies) available for bms 180448 and glyburide
| Article | Year |
|---|---|
Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitors.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Cardiotonic Agents; Cattle; Citrate (si)-Synthase; Electron Transport Complex IV; Hydrolysis; Imidazoles; In Vitro Techniques; Mitochondrial Proton-Translocating ATPases; Myocardial Contraction; Rats; Stereoisomerism; Structure-Activity Relationship | 2004 |
Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Aorta; Benzopyrans; Cromakalim; Decanoic Acids; Dogs; Female; Glyburide; Guanidines; Guinea Pigs; Heart; Heart Ventricles; Hydroxy Acids; In Vitro Techniques; Injections, Intravenous; Injections, Subcutaneous; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1995 |
Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Female; Glyburide; Guanidines; Guinea Pigs; In Vitro Techniques; Ion Channel Gating; Male; Membrane Potentials; Myocardial Infarction; Myocardial Ischemia; Perfusion; Potassium Channels; Pyrroles; Vasodilator Agents | 1995 |
BMS-180448, a novel glyburide-reversible cardioprotective agent, enhances postischemic recovery of contractile function in dogs.
Topics: Animals; Benzopyrans; Cardiotonic Agents; Dogs; Glyburide; Guanidines; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Stunning; Potassium Channels; Rats; Rats, Sprague-Dawley | 1996 |
The novel cardioprotective agent BMS-180448 activates a potassium conductance in cardiac and vascular smooth muscle.
Topics: Animals; Aorta, Thoracic; Benzopyrans; Cardiotonic Agents; Cardiovascular Agents; Cells, Cultured; Clonidine; Glyburide; Guanidines; Guinea Pigs; Heart Ventricles; Male; Muscle, Smooth, Vascular; Myocardium; Patch-Clamp Techniques; Potassium Channels; Rabbits; Rubidium Radioisotopes | 1996 |
Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerations.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Calcium Channel Blockers; Cardiotonic Agents; Depression, Chemical; Diltiazem; Dose-Response Relationship, Drug; Glyburide; Guanidines; Heart; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Myocardial Contraction; Myocardial Ischemia; Oxygen Consumption; Phosphocreatine; Potassium Channels; Rats; Rats, Sprague-Dawley | 1997 |
Effect of timing of treatment of the glyburide-reversible cardioprotective activity of BMS-180448.
Topics: Animals; Benzopyrans; Calcium; Ferrets; Glyburide; Guanidines; Heart; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Potassium Channels; Rats; Time Factors | 1997 |
Comparison of the protective effects of a highly selective ATP-sensitive potassium channel opener and ischemic preconditioning in isolated human atrial muscle.
Topics: Adenosine Triphosphate; Adult; Aged; Analysis of Variance; Angina Pectoris; Benzopyrans; Cardiotonic Agents; Female; Glyburide; Guanidines; Heart; Heart Atria; Humans; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Middle Aged; Myocardial Contraction; Potassium Channels; Vasodilator Agents | 1997 |
Cardioselective antiischemic ATP-sensitive potassium channel (K(ATP)) openers. 6. Effect of modifications at C6 of benzopyranyl cyanoguanidines.
Topics: Animals; Benzopyrans; Cardiotonic Agents; Glyburide; Guanidines; Heart; Muscle Contraction; Myocardial Ischemia; Potassium Channels; Rats; Vasodilation; Vasodilator Agents | 1999 |
Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
Topics: Action Potentials; Animals; Benzopyrans; Cardiovascular Agents; Cromakalim; Decanoic Acids; Dose-Response Relationship, Drug; Glyburide; Guanidines; Guinea Pigs; Heart; Heart Conduction System; Hydroxy Acids; Imidazoles; In Vitro Techniques; Male; Mitochondria; Myocardial Ischemia; Myocardial Reperfusion; Papillary Muscles; Patch-Clamp Techniques; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Vasodilator Agents; Vasomotor System | 2001 |
Cardioprotective effects of (2S,3R,4S)-N'-benzyl-N"-cyano-N-(3,4-dihydro-2-dimethoxymethyl-3-hydroxy-2-methyl-6-nitro-2H-benzopyran-4-yl)-guanidine (KR-31372) in rats and dogs.
Topics: Animals; Benzopyrans; Cardiovascular Agents; Coronary Circulation; Coronary Disease; Dogs; Dose-Response Relationship, Drug; Glyburide; Guanidines; Heart Rate; Hypoglycemic Agents; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction, Left | 2004 |
KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Topics: Animals; Aorta; Benzopyrans; Cardiotonic Agents; Decanoic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Glyburide; Guanidines; Heart Rate; Hydroxy Acids; Indoles; KATP Channels; L-Lactate Dehydrogenase; Male; Membrane Transport Modulators; Methoxamine; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Sarcolemma; Vasoconstrictor Agents; Vasodilation; Ventricular Function, Left; Ventricular Pressure | 2008 |